These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 14695540)

  • 21. Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions.
    Körkkö J; Kaitila I; Lönnqvist L; Peltonen L; Ala-Kokko L
    J Med Genet; 2002 Jan; 39(1):34-41. PubMed ID: 11826022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of six novel FBN1 mutations in British patients affected by Marfan syndrome.
    Comeglio P; Evans AL; Brice GW; Child AH
    Hum Mutat; 2001 Sep; 18(3):251. PubMed ID: 11524736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele.
    Aubart M; Gross MS; Hanna N; Zabot MT; Sznajder M; Detaint D; Gouya L; Jondeau G; Boileau C; Stheneur C
    Hum Mol Genet; 2015 May; 24(10):2764-70. PubMed ID: 25652400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopia lentis as the presenting and primary feature in Marfan syndrome.
    Zadeh N; Bernstein JA; Niemi AK; Dugan S; Kwan A; Liang D; Hyland JC; Hoyme HE; Hudgins L; Manning MA
    Am J Med Genet A; 2011 Nov; 155A(11):2661-8. PubMed ID: 21932315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative and quantitative analysis of FBN1 mRNA from 16 patients with Marfan Syndrome.
    Tjeldhorn L; Amundsen SS; Barøy T; Rand-Hendriksen S; Geiran O; Frengen E; Paus B
    BMC Med Genet; 2015 Dec; 16():113. PubMed ID: 26684006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining clinical examination with exome sequencing for the diagnosis and treatment of Marfan syndrome: a case series of 6 families from China.
    Duan Y; Li P; Ding T; Wang Y; Liao Y; Du Z; Ling J; Liu S; Li W; Liu Z
    Ann Palliat Med; 2021 Sep; 10(9):9953-9962. PubMed ID: 34628919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: Identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene.
    Mátyás G; De Paepe A; Halliday D; Boileau C; Pals G; Steinmann B
    Hum Mutat; 2002 Apr; 19(4):443-56. PubMed ID: 11933199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of dHPLC for mutation detection of the fibrillin-1 gene for the diagnosis of Marfan syndrome in a National Health Service Laboratory.
    Howarth R; Yearwood C; Harvey JF
    Genet Test; 2007; 11(2):146-52. PubMed ID: 17627385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes.
    Schrijver I; Liu W; Odom R; Brenn T; Oefner P; Furthmayr H; Francke U
    Am J Hum Genet; 2002 Aug; 71(2):223-37. PubMed ID: 12068374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome.
    Hung CC; Lin SY; Lee CN; Cheng HY; Lin SP; Chen MR; Chen CP; Chang CH; Lin CY; Yu CC; Chiu HH; Cheng WF; Ho HN; Niu DM; Su YN
    Ann Hum Genet; 2009 Nov; 73(Pt 6):559-67. PubMed ID: 19839986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes.
    Schrijver I; Liu W; Brenn T; Furthmayr H; Francke U
    Am J Hum Genet; 1999 Oct; 65(4):1007-20. PubMed ID: 10486319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marfan syndrome--a diagnostic challenge caused by phenotypic and genetic heterogeneity.
    Baumgartner C; Mátyás G; Steinmann B; Baumgartner D
    Methods Inf Med; 2005; 44(4):487-97. PubMed ID: 16342915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion.
    Faivre L; Collod-Beroud G; Callewaert B; Child A; Loeys BL; Binquet C; Gautier E; Arbustini E; Mayer K; Arslan-Kirchner M; Kiotsekoglou A; Comeglio P; Grasso M; Beroud C; Bonithon-Kopp C; Claustres M; Stheneur C; Bouchot O; Wolf JE; Robinson PN; Adès L; De Backer J; Coucke P; Francke U; De Paepe A; Boileau C; Jondeau G
    Am J Med Genet A; 2009 May; 149A(5):854-60. PubMed ID: 19353630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders.
    Liu WO; Oefner PJ; Qian C; Odom RS; Francke U
    Genet Test; 1997-1998; 1(4):237-42. PubMed ID: 10464652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype.
    Gupta PA; Putnam EA; Carmical SG; Kaitila I; Steinmann B; Child A; Danesino C; Metcalfe K; Berry SA; Chen E; Delorme CV; Thong MK; Adès LC; Milewicz DM
    Hum Mutat; 2002 Jan; 19(1):39-48. PubMed ID: 11754102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two novel mutations in fibrillin-1 gene of Marfan syndrome].
    Huang X; Wu Y; Chen F; Huang Y; Ma X; Chen T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):562-5. PubMed ID: 15583982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homozygosity for a FBN1 missense mutation: clinical and molecular evidence for recessive Marfan syndrome.
    de Vries BB; Pals G; Odink R; Hamel BC
    Eur J Hum Genet; 2007 Sep; 15(9):930-5. PubMed ID: 17568394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical spectrum of complete FBN1 allele deletions.
    Hilhorst-Hofstee Y; Hamel BC; Verheij JB; Rijlaarsdam ME; Mancini GM; Cobben JM; Giroth C; Ruivenkamp CA; Hansson KB; Timmermans J; Moll HA; Breuning MH; Pals G
    Eur J Hum Genet; 2011 Mar; 19(3):247-52. PubMed ID: 21063442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome.
    Cecchi A; Ogawa N; Martinez HR; Carlson A; Fan Y; Penny DJ; Guo DC; Eisenberg S; Safi H; Estrera A; Lewis RA; Meyers D; Milewicz DM
    Am J Med Genet A; 2013 Sep; 161A(9):2305-10. PubMed ID: 23897642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype-phenotype correlation.
    Pepe G; Giusti B; Evangelisti L; Porciani MC; Brunelli T; Giurlani L; Attanasio M; Fattori R; Bagni C; Comeglio P; Abbate R; Gensini GF
    Clin Genet; 2001 Jun; 59(6):444-50. PubMed ID: 11453977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.